Scott Dahlbeck - 11 Aug 2022 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBPQ)

Role
Chief of Staff
Signature
/s/ Scott Dahlbeck
Issuer symbol
KRBPQ
Transactions as of
11 Aug 2022
Net transactions value
$0
Form type
4
Filing time
15 Aug 2022, 16:31:47 UTC
Previous filing
25 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRBP Common Stock Award $0 +50,000 +11% $0.000000 496,757 11 Aug 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") and will be settled in common stock as soon as practicable within 60 days following vesting. The RSUs vested on August 11, 2022.
F2 Includes (i) 50,000 shares of common stock underlying the RSUs and (ii) 446,757 shares of common stock.